Forventes på lager: 08-01-2019
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
| Forlag | Springer Nature Switzerland AG |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | Softcover Reprint of the Original 1st 2018 ed. |
| Udgivelsesdato | 08-01-2019 |
| Første udgivelsesår | 2019 |
| Serie | Resistance to Targeted Anti-Cancer Therapeutics |
| Illustrationer | 14 Illustrations, color; 4 Illustrations, black and white |
| Fagredaktør | Makoto Hosono, Jean-Francois Chatal |
| Originalsprog | Switzerland |
| Sideantal | 158 |
| Indbinding | Paperback / softback |
| Forlag | Springer Nature Switzerland AG |
| Sideoplysninger | 158 pages, 14 Illustrations, color; 4 Illustrations, black and white |
| Mål | 235 x 155 |
| ISBN-13 / EAN-13 | 9783030086527 |